Skip to main content
. Author manuscript; available in PMC: 2016 Jun 8.
Published in final edited form as: J Neuroimmune Pharmacol. 2010 Dec 24;6(3):389–398. doi: 10.1007/s11481-010-9254-3

Table 2.

Cognitive function (mean ± SE)

Seronegative controls
HIV+ subjects
n=39
n=48
ε4+ (n=11) ε4− (n=28) ε4+ (n=15) ε4− (n=33) p Value
Learning 0.45±0.17 0.27±0.10 −0.37±0.25*, ** 0.11±0.14 0.02
Fluency 0.54±0.17 0.26±0.09 −0.21±0.18*, ** 0.30±0.15 0.05
Memory 0.60±0.16 0.27±0.11 −0.34±0.23*, ** 0.10±0.15 0.01
Attention −0.15±0.23 0.05±0.14 −0.70±0.17** −0.37±0.14*** 0.02
Executive Function 0.09±0.26 0.07±0.14 −0.35±0.17 0.14±0.20 0.39
Motor 0.01±0.22 −0.18±0.16 −0.25±0.25 −0.15±0.17 0.91
Speed 0.05±0.22 −0.08±0.12 −0.26±0.16 −0.14±0.12 0.67
Global cognitive score 0.23±0.14 0.10±0.08 −0.35±0.12*, ** −0.002±0.11 0.02
*

p<0.05, for ε4+ HIV+ vs. ε4+ SN control

**

p<0.05, for ε4+ HIV+ vs. ε4− SN control

***

p<0.05 for ε4− HIV+ vs. ε4− SN control